Downstream Processing Featured Articles

  1. 3M Purification Inc. Introduces New Zeta Plus Encapsulated, Single-Use Depth Filtration Products 5/4/2012

    3M Purification Inc. has expanded its portfolio of Encapsulated Zeta Plus single-use depth filtration capsules.  The two new product lines – Zeta Plus Scale-up Capsule Filters and new single-layer media grades for Zeta Plus Encapsulated capsules – are designed with our industry leading Zeta Plus depth filter media, designed for applications in the bio-pharmaceutical industry including cell culture clarification, downstream process protection, virus, DNA and lipid reduction, and host cell protein (HCP), protein aggregate, endotoxin and anti-foaming agent removal.

  2. NIH Researchers Implicate Unique Cell Type In Multiple Sclerosis 8/1/2012

    Researchers at the National Institutes of Health have found evidence that a unique type of immune cell contributes to multiple sclerosis (MS). 

  3. Investigational Brain Cancer Vaccine To Be Tested In Phase I Roswell Park Study 9/27/2012

    A new clinical research study at Roswell Park Cancer Institute(RPCI) will test a first-of-its-kind cancer “vaccine” that may prove effective against many forms of solid-tumor cancers.

  4. Cangene Announces Closing Of Acquisition Of Late Stage Hemophilia B Product 2/20/2013

    Cangene Corporation (Cangene) today announces the closing of the acquisition of the investigational hemophilia compound IB1001 and certain other assets from Ipsen and Inspiration Biopharmaceuticals, Inc. in connection with Inspiration's bankruptcy proceedings.

  5. Automation To Solve Sample Lysis Bottleneck For Molecular Biology Labs 11/20/2012

    Hamilton Robotics is launching the Microlab AutoLys STAR workstation, which automates sample lysis and DNA extraction. This innovative instrument improves bottlenecks for forensic scientists and other molecular biologists isolating nucleic acids from samples.

  6. Thallion And LFB Terminate Shigamabs Collaboration 2/20/2013

    Thallion Pharmaceuticals Inc. (TSX-V: TLN) ("Thallion") and LFB Biotechnologies ("LFB") today announced that they have reached an agreement on the termination of their Development and Licensing Agreement related to Thallion's Shigamabs® program.

  7. Taiho Pharmaceutical Announces Start Of Global Phase III Clinical Trial In Metastatic Colorectal Cancer With Novel Antitumor Agent TAS-102 5/31/2012

    Taiho Pharmaceutical Co., Ltd. announced on May 31 that a global Phase III clinical trial (RECOURSE) for the novel combination antimetabolite TAS-102 will start in June this year.

  8. Announcing High Quality Borosilicate Glass Centrifuge Tubes 11/21/2011
    Chemists are finding the optimal centrifuge tubes they need at Kimble Chase, the largest manufacturer of laboratory glassware products in the world.
  9. RNA-Based Therapy Brings New Hope For An Incurable Blood Cancer 10/10/2012

    Three thousand new cases of Mantle Cell Lymphoma (MCL), a form of blood cancer, appear in the United States each year. With a median survival span of only five to seven years, according to the Leukemia and Lymphoma Society, this disease is devastating, and new therapies are sorely needed.

  10. Evotec Acquires Cell Culture Service GmbH 1/3/2013

    Evotec AG recently announced the acquisition of all shares in Cell Culture Service GmbH (CCS), a Hamburg-based company which supports the cell culture needs of a world-wide customer base of biotech and Pharmaceutical companies.